24 May 2019 - - The US Food and Drug Administration (FDA) has approved a revised product label for Octapharma USA's Octaplas, Pooled Plasma (Human), Solvent/Detergent Treated Solution for Intravenous Infusion.
The ne...
You are required to be logged in to access the full website
Click here if you have forgotten your username or password
Therapy Areas
24 May 2019 - - US-based biotechnology company Progenity, Inc has received results from three studies that represent potential breakthrough systems for diagnosing, treating, and monitoring digestive diseases through ingestible technologies, the ...
24 May 2019 - - US-based Celsius Therapeutics, a company translating single-cell genomic insights into precision therapeutics for patients with autoimmune diseases and cancer, has made its first key leadership appointments, the company said.
24 May 2019 - - US-based clinical stage company Synlogic, Inc., (NASDAQ: SYBX) has forged a new clinical collaboration with Swiss healthcare company Roche (SIX: RO), to explore Synlogic's Synthetic Biotic medicine, SYNB1891, a dual innate i...
24 May 2019 - - The US Food and Drug Administration (FDA) has approved a revised product label for Octapharma USA's Octaplas, Pooled Plasma (Human), Solvent/Detergent Treated Solution for Intravenous Infusion.
The ne...
The ne...
24 May 2019 - - US-based Celsius Therapeutics, a company translating single-cell genomic insights into precision therapeutics for patients with autoimmune diseases and cancer, has made its first key leadership appointments, the company said.
24 May 2019 - - US-based biopharmaceutical company Celgene Corp. (NASDAQ: CELG) and the Multiple Sclerosis Association of America have launched of a new campaign, MS MindShift: A New View of MS, a national initiative that provides new perspectiv...